NICE
Dermatology
Subcutaneous spesolimab 1-ml formulation for preventing generalised pustular psoriasis flares in people 12 years and over (terminated appraisal)
This NICE publication is marked as a terminated appraisal, so it functions as a status notice rather than an active treatment recommendation for routine…
08 Apr 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment
Digital spirometry algorithms can improve diagnostic accuracy for asthma and COPD in primary care and community diagnostic centres, potentially reducing unnecessary referrals to secondary…
02 Apr 2026
Read summary →
Respiratory / COPD / Asthma
GOLD 2025 Report: Global Strategy for Prevention, Diagnosis and Management of COPD
GOLD 2025 updates COPD diagnosis criteria: spirometry FEV1/FVC
31 Mar 2026
Read summary →
Respiratory / COPD / Asthma
GINA 2024 Report: Global Strategy for Asthma Management and Prevention
GINA 2024 reinforces no SABA-only treatment for any asthma severity: all patients should receive ICS-containing controller therapy or ICS-formoterol MART as first-line to reduce…
31 Mar 2026
Read summary →
Oncology
EMA Reflection Paper on Extrapolation of Efficacy in Oncology
This EMA guideline addresses EMA Reflection Paper on Extrapolation of Efficacy in Oncology in Oncology. Use it to review current recommendation wording, eligibility criteria,…
30 Mar 2026
Read summary →
Haematology
2023 EHA Guidelines on the Management of Myeloma
This EHA guideline addresses 2023 EHA Guidelines on the Management of Myeloma in Haematology. Use it to review current recommendation wording, eligibility criteria, and…
30 Mar 2026
Read summary →
Gastroenterology
2022 ESPGHAN Guidelines on Coeliac Disease Diagnosis
This ESPGHAN guideline addresses 2022 ESPGHAN Guidelines on Coeliac Disease Diagnosis in Gastroenterology. Use it to review current recommendation wording, eligibility criteria, and implementation…
30 Mar 2026
Read summary →
Cardiology / Cardiovascular
EMA Guideline on Clinical Investigation of Medicinal Products for Heart Failure
This EMA guideline addresses EMA Guideline on Clinical Investigation of Medicinal Products for Heart Failure in Cardiology / Cardiovascular. Use it to review current…
30 Mar 2026
Read summary →
Neurology
2022 EAN/EFNS Guidelines on Dementia Diagnosis and Management
This EAN guideline addresses 2022 EAN/EFNS Guidelines on Dementia Diagnosis and Management in Neurology. Use it to review current recommendation wording, eligibility criteria, and…
30 Mar 2026
Read summary →
ESCMID
Infectious Disease
2022 ESCMID Guidelines on Candidaemia and Invasive Candidiasis
This ESCMID guideline addresses 2022 ESCMID Guidelines on Candidaemia and Invasive Candidiasis in Infectious Disease. Use it to review current recommendation wording, eligibility criteria,…
30 Mar 2026
Read summary →
Neurology
2023 EAN Guidelines on the Management of Multiple Sclerosis
This EAN guideline addresses 2023 EAN Guidelines on the Management of Multiple Sclerosis in Neurology. Use it to review current recommendation wording, eligibility criteria,…
30 Mar 2026
Read summary →
Neurology
2022 EAN Guidelines on Epilepsy Management in Adults
This EAN guideline addresses 2022 EAN Guidelines on Epilepsy Management in Adults in Neurology. Use it to review current recommendation wording, eligibility criteria, and…
30 Mar 2026
Read summary →
Rheumatology
2023 EULAR Recommendations for Systemic Lupus Erythematosus
This EULAR guideline addresses 2023 EULAR Recommendations for Systemic Lupus Erythematosus in Rheumatology. Use it to review current recommendation wording, eligibility criteria, and implementation…
30 Mar 2026
Read summary →
ESCMID
Respiratory / COPD / Asthma
2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia
This ESCMID guideline addresses 2021 ESCMID Guidelines for the Management of Community-acquired Pneumonia in Respiratory / COPD / Asthma. Use it to review current…
30 Mar 2026
Read summary →
Rheumatology
2022 EULAR Recommendations for the Management of Rheumatoid Arthritis
This EULAR guideline addresses 2022 EULAR Recommendations for the Management of Rheumatoid Arthritis in Rheumatology. Use it to review current recommendation wording, eligibility criteria,…
30 Mar 2026
Read summary →
Rheumatology
2023 EULAR Recommendations for the Management of Gout
This EULAR guideline addresses 2023 EULAR Recommendations for the Management of Gout in Rheumatology. Use it to review current recommendation wording, eligibility criteria, and…
30 Mar 2026
Read summary →
ESMO
Oncology
2023 ESMO Clinical Practice Guideline: Early Breast Cancer
Focuses on multidisciplinary management of early breast cancer including surgery, radiation, and systemic therapy • Covers genetic testing recommendations (BRCA, PD-L1, HER2) and how…
30 Mar 2026
Read summary →
ESMO
Oncology
2023 ESMO Clinical Practice Guidelines: Metastatic Non-Small Cell Lung Cancer
Covers diagnostic workup and molecular profiling for metastatic non-small cell lung cancer (NSCLC) • Provides treatment algorithms based on biomarker status (EGFR, ALK, ROS1,…
30 Mar 2026
Read summary →
Gastroenterology
2023 EASL Clinical Practice Guidelines on Cirrhosis
This EASL guideline addresses 2023 EASL Clinical Practice Guidelines on Cirrhosis in Gastroenterology. Use it to review current recommendation wording, eligibility criteria, and implementation…
30 Mar 2026
Read summary →
Gastroenterology
2023 EASL-EASD-EASO Clinical Practice Guidelines for MASLD
This EASL guideline addresses 2023 EASL-EASD-EASO Clinical Practice Guidelines for MASLD in Gastroenterology. Use it to review current recommendation wording, eligibility criteria, and implementation…
30 Mar 2026
Read summary →
EASD/ESC
Diabetes / Metabolic
2022 EASD/ESC Guidelines on Diabetes and Cardiovascular Disease
This EASD guideline addresses 2022 EASD/ESC Guidelines on Diabetes and Cardiovascular Disease in Diabetes / Metabolic. Use it to review current recommendation wording, eligibility…
30 Mar 2026
Read summary →
Gastroenterology
2022 EASL Clinical Practice Guidelines on Hepatitis C
This EASL guideline addresses 2022 EASL Clinical Practice Guidelines on Hepatitis C in Gastroenterology. Use it to review current recommendation wording, eligibility criteria, and…
30 Mar 2026
Read summary →
ESC/ERS
Respiratory / COPD / Asthma
2022 ERS/ESC Guidelines on Pulmonary Hypertension
This ERS guideline addresses 2022 ERS/ESC Guidelines on Pulmonary Hypertension in Respiratory / COPD / Asthma. Use it to review current recommendation wording, eligibility…
30 Mar 2026
Read summary →
ERS
Respiratory / COPD / Asthma
2023 ERS Guidelines on Sleep-disordered Breathing
This ERS guideline addresses 2023 ERS Guidelines on Sleep-disordered Breathing in Respiratory / COPD / Asthma. Use it to review current recommendation wording, eligibility…
30 Mar 2026
Read summary →
ERS/ATS
Respiratory / COPD / Asthma
2023 ERS/ATS Guidelines on COPD Exacerbations
Covers diagnosis and assessment of COPD exacerbations including severity grading • Provides recommendations for pharmacologic management (bronchodilators, steroids, antibiotics) • Addresses indications for non-invasive…
30 Mar 2026
Read summary →
ERS
Respiratory / COPD / Asthma
2022 ERS Guidelines on Idiopathic Pulmonary Fibrosis
Covers diagnostic criteria for idiopathic pulmonary fibrosis (IPF) including HRCT patterns • Provides recommendations for antifibrotic therapy and patient selection • Addresses management of…
30 Mar 2026
Read summary →
ESC
Cardiology / Cardiovascular
2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias
Covers risk stratification for sudden cardiac death and indications for ICD implantation • Provides management recommendations for ventricular tachycardia and ventricular fibrillation • Addresses…
30 Mar 2026
Read summary →
ESC
Cardiology / Cardiovascular
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
Covers indications for cardiac pacing and cardiac resynchronization therapy (CRT) • Provides guidance on device selection, implantation techniques, and optimization • Addresses follow-up protocols,…
30 Mar 2026
Read summary →
ESC
Cardiology / Cardiovascular
2024 ESC Guidelines for the Management of Atrial Fibrillation
Covers AF classification, stroke risk assessment (CHA2DS2-VASc), and bleeding risk (HAS-BLED) • Provides recommendations for rate vs rhythm control strategies • Addresses anticoagulation choices…
30 Mar 2026
Read summary →
ESC
Cardiology / Cardiovascular
2023 ESC Guidelines on the Management of Endocarditis
Covers diagnostic criteria for infective endocarditis (Duke criteria) and appropriate imaging modalities • Provides antimicrobial treatment recommendations based on causative organisms and valve involvement…
30 Mar 2026
Read summary →
ESC
Cardiology / Cardiovascular
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
Covers rapid diagnosis and risk stratification for acute coronary syndromes (ACS) including STEMI and NSTEMI • Provides evidence-based recommendations for reperfusion strategies (PCI vs…
30 Mar 2026
Read summary →
NICE
Dermatology
Hidradenitis Suppurativa: Assessment and Management (NICE NG73)
Diagnose hidradenitis suppurativa clinically based on recurrent painful nodules, abscesses, sinus tracts, and scars localised to intertriginous areas (axillae, groin, inframammary folds), then assess…
27 Mar 2026
Read summary →
NICE
Dermatology
Atopic Eczema in Under 12s: Diagnosis and Management (NICE NG190)
Diagnose atopic eczema clinically based on itching, typical morphology and distribution, onset before age 2 years, and history of dry skin or atopic disease;…
27 Mar 2026
Read summary →
NICE
Women's Health
Polycystic Ovary Syndrome (NICE NG88 / RCOG Guidelines)
Diagnose PCOS using Rotterdam criteria (≥2 of: irregular periods, clinical/biochemical hyperandrogenism, or polycystic ovaries on ultrasound) after excluding other diagnoses, then assess cardiovascular risk…
27 Mar 2026
Read summary →
NICE
Women's Health
Endometriosis: Diagnosis and Management (NICE NG73)
Suspect endometriosis in women presenting with chronic pelvic pain, dysmenorrhoea, or deep dyspareunia; refer to gynaecology if symptoms persist after adequate trial of NSAIDs…
27 Mar 2026
Read summary →
NICE
Men's Health
Erectile Dysfunction: Assessment and Management (NICE CG1097)
Take a sexual history exploring onset, severity, partner concerns and quality of life impact; simultaneously assess cardiovascular risk and screen for diabetes, hypertension, hyperlipidaemia,…
27 Mar 2026
Read summary →
NICE
Infectious Disease
HIV Testing: Increasing Uptake Among People Who May Have Undiagnosed HIV (NICE PH33)
Offer opt-out HIV testing in emergency departments, sexual health clinics, and antenatal services to maximise identification of undiagnosed HIV cases without requiring explicit patient…
27 Mar 2026
Read summary →
NICE
Infectious Disease
Pneumonia in Adults: Diagnosis and Management (NICE CG191)
Use CRB65 score in primary care to stratify CAP severity (1 point each for confusion, respiratory rate ≥30, systolic BP
27 Mar 2026
Read summary →
NICE
Infectious Disease
Sepsis: Recognition, Diagnosis and Early Management (NICE NG51)
Use qSOFA tool (altered mental state, systolic BP ≤100 mmHg, respiratory rate ≥22) or NEWS2 score to identify suspected sepsis in adults and escalate…
27 Mar 2026
Read summary →
NICE
Gastroenterology
Pancreatitis (NICE NG104)
Confirm acute pancreatitis diagnosis using serum lipase (or amylase if unavailable) with characteristic clinical features; perform baseline assessment including FBC, U&Es, LFTs, glucose, calcium,…
27 Mar 2026
Read summary →
NICE
Gastroenterology
Hepatitis B (Chronic): Diagnosis and Management (NICE NG133)
Assess all newly diagnosed chronic hepatitis B patients with HBsAg, anti-HBc, HBeAg, anti-HBe, quantitative HBV DNA, ALT, and liver function tests before treatment decisions…
27 Mar 2026
Read summary →
NICE
Gastroenterology
Coeliac Disease: Recognition, Assessment and Management (NICE NG20)
Test for coeliac disease using tissue transglutaminase (tTG) IgA antibodies as first-line serology, with concurrent total IgA measurement; if IgA deficient, use IgG-based tests…
27 Mar 2026
Read summary →
NICE
Gastroenterology
Irritable Bowel Syndrome in Adults: Diagnosis and Management (NICE CG61)
Offer structured dietary and lifestyle advice as first-line treatment, including consideration of a low FODMAP diet if standard measures are insufficient, before prescribing antispasmodics,…
27 Mar 2026
Read summary →
NICE
Rheumatology
Osteoarthritis: Care and Management (NICE CG177)
Offer all patients with osteoarthritis structured information about self-management, weight management, and both land-based and aquatic exercise programmes as first-line treatment before considering pharmacological…
27 Mar 2026
Read summary →
NICE
Rheumatology
Axial Spondyloarthritis: Diagnosis and Management (NICE NG65)
Refer adults to rheumatology if they present with chronic back pain (≥3 months) plus any of: inflammatory back pain features, elevated inflammatory markers, HLA-B27…
27 Mar 2026
Read summary →
NICE
Rheumatology
Gout: Diagnosis and Management (NICE NG219)
Diagnose acute gout clinically (sudden joint pain, erythema, swelling) and confirm with serum urate level plus polarising microscopy of synovial fluid showing needle-shaped monosodium…
27 Mar 2026
Read summary →
NICE
Rheumatology
Osteoporosis: Assessing the Risk of Fragility Fracture (NICE CG146)
Use DEXA scan to measure BMD in women aged ≥65 years, men aged ≥70 years, and younger adults with osteoporosis risk factors • Use…
27 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Obsessive-Compulsive Disorder and Body Dysmorphic Disorder (NICE CG31)
Diagnose OCD and BDD through systematic assessment of intrusive thoughts, images or impulses combined with repetitive behaviours or mental acts that cause significant distress…
27 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Self-Harm: Assessment, Management and Preventing Recurrence (NICE NG225)
Conduct comprehensive psychosocial assessment within 48 hours of all self-harm presentations (including low-lethality harm) to inform risk stratification and care planning, followed by follow-up…
27 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Eating Disorders: Recognition and Treatment (NICE NG69)
Use SCOFF questionnaire or validated screening tool in primary care to assess for weight loss, food restriction, compensatory behaviours and body image concerns when…
27 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Post-Traumatic Stress Disorder (NICE NG116)
Offer trauma-focused cognitive behavioural therapy (TF-CBT) or eye movement desensitisation and reprocessing (EMDR) as first-line psychological treatment, delivered by trained practitioners for 8–12 sessions…
27 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
ADHD: Diagnosis and Management (NICE NG87)
Refer suspected ADHD cases (presenting with inattention, hyperactivity, impulsivity, or functional impairment) to specialist services (paediatrician, psychiatrist, or specialist ADHD nurse) for diagnosis using…
27 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Bipolar Disorder: Assessment and Management (NICE NG185)
Refer urgently to specialist psychiatry if bipolar disorder is suspected; diagnosis must be made by specialists using ICD-10 or DSM-5 criteria For acute mania…
27 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Schizophrenia: Psychosis and Schizophrenia in Adults (NICE NG224)
Offer oral antipsychotics as first-line treatment for first-episode psychosis at the lowest effective dose, with long-acting injectables reserved for patients with adherence concerns or…
27 Mar 2026
Read summary →
NICE
Neurology
Transient Loss of Consciousness (NICE CG109)
Obtain detailed witness account documenting prodrome, colour during episode, duration of unconsciousness, injury pattern, and postictal confusion to distinguish between syncope and seizure Perform…
27 Mar 2026
Read summary →
NICE
Neurology
Motor Neurone Disease: Assessment and Management (NICE NG42)
Refer suspected MND urgently to a specialist neurology centre for diagnosis confirmation by an MND-experienced neurologist using clinical examination, EMG/NCS, imaging, and genetic testing…
27 Mar 2026
Read summary →
NICE
Neurology
Stroke Rehabilitation in Adults (NICE NG236)
Initiate mobilisation within 24 hours of stroke admission and perform swallowing assessment before allowing oral intake to prevent aspiration complications Deliver structured, task-specific, repetitive…
27 Mar 2026
Read summary →
NICE
Neurology
Headaches in Over 12s: Diagnosis and Management (NICE CG150)
Take a focused history documenting headache onset, frequency, duration, severity, associated symptoms, and functional impact to distinguish primary headaches from secondary causes requiring investigation…
27 Mar 2026
Read summary →
NICE
Neurology
Multiple Sclerosis in Adults: Management (NICE NG220)
Initiate disease-modifying therapy (DMT) in all adults with relapsing-remitting MS immediately upon diagnosis using first-line agents (interferon beta, glatiramer acetate, or teriflunomide), escalating to…
27 Mar 2026
Read summary →
NICE
Oncology
Head and Neck Cancers: Diagnosis and Management (NICE NG36)
Refer urgently (two-week wait) any adult with unexplained persistent hoarseness, dysphagia, otalgia, oral ulceration lasting more than 3 weeks, or suspicious neck lump for…
27 Mar 2026
Read summary →
NICE
Oncology
Multiple Myeloma: Diagnosis and Management (NICE NG35)
Proteasome inhibitors (bortezomib, carfilzomib) combined with immunomodulatory drugs (lenalidomide) and dexamethasone have become standard first-line therapy for transplant-eligible myeloma patients. Daratumumab (anti-CD38 monoclonal antibody)…
27 Mar 2026
Read summary →
NICE
Oncology
Melanoma: Assessment and Management (NICE NG14)
Excise primary melanomas with 2 cm margins if Breslow thickness ≤2 mm, or 1–2 cm margins if >2 mm, tailored to tumour characteristics and…
27 Mar 2026
Read summary →
NICE
Oncology
Colorectal Cancer: Diagnosis and Management (NICE NG151)
Refer adults with rectal bleeding plus abdominal pain, change in bowel habit, weight loss, iron-deficiency anaemia, or age >60 with unexplained symptoms for urgent…
27 Mar 2026
Read summary →
NICE
Diabetes / Metabolic
Tirzepatide for Managing Overweight and Obesity (NICE TA1026)
Prescribe tirzepatide to adults with BMI ≥35 kg/m² or BMI 30–34.9 kg/m² with weight-related comorbidities, initiating treatment in specialist weight management services or trained…
27 Mar 2026
Read summary →
NICE
Diabetes / Metabolic
Semaglutide for Managing Overweight and Obesity (NICE TA875)
Initiate semaglutide only in specialist obesity services or via shared care with clear primary-secondary care protocols for adults with BMI ≥30 kg/m² or BMI…
27 Mar 2026
Read summary →
NICE
Diabetes / Metabolic
Gestational Diabetes: Diagnosis and Treatment (NICE NG3)
Perform a 2-hour 75 g OGTT between 24–28 weeks in women with GDM risk factors; diagnose GDM if fasting glucose ≥5.6 mmol/L or 2-hour…
27 Mar 2026
Read summary →
NICE
Diabetic Foot Problems: Prevention and Management (NICE NG19)
Perform annual foot risk assessment using structured approach in all people with diabetes; stratify those with sensory neuropathy, reduced ankle mobility, or previous ulceration…
27 Mar 2026
Read summary →
NICE
Diabetes / Metabolic
Non-Alcoholic Fatty Liver Disease: Assessment and Management (NICE NG49)
Use FIB-4 or NAFLD Fibrosis Score in primary care to stratify fibrosis risk in adults with metabolic risk factors (type 2 diabetes, obesity, metabolic…
27 Mar 2026
Read summary →
NICE
Diabetes / Metabolic
Obesity: Identification, Assessment and Management (NICE CG189)
Use BMI thresholds to identify obesity (≥30 kg/m² in adults; ≥27.5 kg/m² in Asian populations) and offer structured first-line weight loss interventions combining 600…
27 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Dupilumab for Treating Moderate-to-Severe Atopic Dermatitis (NICE TA534)
Initiate dupilumab in adults and adolescents aged 12+ with moderate-to-severe atopic dermatitis only when topical corticosteroids have failed or are inadvisable, using induction dose…
27 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Mepolizumab for Treating Severe Refractory Eosinophilic Asthma (NICE TA431)
Initiate mepolizumab 100 mg subcutaneously once monthly only in adults with severe eosinophilic asthma inadequately controlled on high-dose inhaled corticosteroids plus long-acting beta-2 agonists,…
27 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Bronchiectasis (non-CF): Diagnosis and Management (NICE NG117)
Suspect bronchiectasis in patients presenting with chronic productive cough or recurrent respiratory infections and refer for High-Resolution CT chest imaging; investigate all newly diagnosed…
27 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Obstructive Sleep Apnoea/Hypopnoea Syndrome (NICE NG202)
Use STOP-BANG questionnaire in primary care to screen for OSAHS and refer to sleep services if clinical suspicion is high based on excessive daytime…
27 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Idiopathic Pulmonary Fibrosis: Diagnosis and Management (NICE NG163)
Suspect IPF in adults aged >50 presenting with unexplained progressive dyspnoea, cough, or fatigue with significant smoking history or occupational exposure, and refer urgently…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Empagliflozin for Treating Chronic Heart Failure with Reduced Ejection Fraction (NICE TA773)
Initiate empagliflozin 10 mg once daily as add-on therapy to standard HFrEF treatment (ACE inhibitors, beta-blockers, and aldosterone antagonists) in adults with reduced ejection…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Aortic Valve Disease: TAVI and Surgical Replacement (NICE TA631)
Offer TAVI as first-line intervention for symptomatic aortic stenosis in patients at high or prohibitive surgical risk, or with severe comorbidities precluding surgery, following…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Stroke and TIA: Diagnosis and Initial Management (NICE NG128)
Use FAST recognition (Face, Arms, Speech, Time) in primary care to identify suspected stroke and arrange immediate hospital admission as a medical emergency Assess…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Peripheral Arterial Disease: Diagnosis and Management (NICE CG147)
Use ABPI measurement as first-line investigation in primary care; refer to secondary care if ABPI ≤0.9 • Prescribe aspirin 75 mg daily for all…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Cardiovascular Disease: Risk Assessment and Reduction (NICE NG238)
Perform CVD risk assessment using Framingham equation or QRISK3 in all adults aged 40–74 years; initiate atorvastatin 20 mg daily if 10-year risk ≥10%…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Venous Thromboembolic Diseases (NICE NG158)
Use two-level Wells score or revised Geneva score combined with D-dimer testing in low-risk suspected PE; proceed directly to CT pulmonary angiography in high-risk…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Stable Angina: Management (NICE CG126)
Initiate all stable angina patients on beta-blocker or rate-limiting calcium channel blocker (diltiazem/verapamil) plus aspirin and high-intensity statin; add ACE inhibitor if left ventricular…
27 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Heart Failure: Diagnosis and Management (NICE NG106)
Use NT-BNP or BNP testing in primary care to rule out heart failure; refer urgently to secondary care if elevated with compatible symptoms, and…
27 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils
Dupilumab is recommended for maintenance treatment of uncontrolled COPD only in patients with blood eosinophil count ≥400 cells/μL, as this biomarker predicts treatment response…
26 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Depression in Adults: Treatment and Management (NICE NG222)
Abandon severity-based classification and instead assess each patient's individual need, preference, and symptom severity to personalise treatment selection • Offer explicit choice between psychological…
25 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Generalised Anxiety Disorder and Panic Disorder in Adults (NICE CG113)
Initiate treatment with education and self-help resources (bibliotherapy); escalate to individual CBT or applied relaxation only if insufficient response • Prescribe sertraline as first-line…
25 Mar 2026
Read summary →
NICE
Neurology
Dementia: Assessment, Management and Support (NICE NG97)
Use cognitive testing (MMSE or MoCA) combined with appropriate imaging to confirm dementia diagnosis • Prescribe acetylcholinesterase inhibitors (donepezil, rivastigmine, or galantamine) for mild-moderate…
25 Mar 2026
Read summary →
NICE
Neurology
Epilepsies: Diagnosis and Management (NICE NG217, 2022 update)
Refer patients with suspected first seizure to an epilepsy specialist within 2 weeks of presentation For focal onset seizures, initiate lamotrigine or levetiracetam as…
25 Mar 2026
Read summary →
NICE
Oncology
Early Breast Cancer: Diagnosis and Management (NICE NG101)
Perform triple assessment (clinical examination, imaging, and biopsy) for all suspicious breast lesions to confirm diagnosis before treatment planning Offer breast-conserving surgery with axillary…
25 Mar 2026
Read summary →
NICE
Infectious Disease
Antimicrobial Stewardship: Systems and Processes for Effective Antimicrobial Medicine Use (NICE NG15)
Document the clinical indication, dose, route, and planned review/stop date on every antibiotic prescription at the point of initiation Review all intravenous antibiotic therapy…
25 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Hypertension in Adults: Diagnosis and Management (NICE NG136)
Diagnose hypertension using clinic BP ≥140/90 mmHg confirmed with ambulatory or home blood pressure monitoring, then initiate treatment if stage 1 hypertension with age…
25 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Acute Coronary Syndromes (NICE NG185)
Initiate dual antiplatelet therapy with aspirin plus ticagrelor or prasugrel for all NSTEMI patients unless contraindicated, continuing for 12 months post-ACS unless bleeding risk…
25 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Atrial Fibrillation: Diagnosis and Management (NICE NG196)
Use CHA2DS2-VASc score to stratify stroke risk and offer anticoagulation to men scoring ≥2 and women scoring ≥3 (consider treatment at scores of ≥1…
25 Mar 2026
Read summary →
NICE
Diabetes / Metabolic
Type 2 Diabetes in Adults: Management (NICE NG28, 2024 Update)
Initiate metformin as first-line therapy in type 2 diabetes unless eGFR
25 Mar 2026
Read summary →
NICE
Diabetes / Metabolic
Type 1 Diabetes in Adults: Diagnosis and Management (NICE NG17)
Offer multiple daily injection (MDI) basal-bolus insulin regimen as first-line treatment for all adults with type 1 diabetes, with continuous subcutaneous insulin infusion (CSII)…
25 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management (NICE NG115)
Confirm COPD diagnosis with spirometry showing post-bronchodilator FEV1/FVC ratio
25 Mar 2026
Read summary →
NICE
Respiratory / COPD / Asthma
Asthma: Diagnosis, Monitoring and Chronic Asthma Management (NICE NG80/BTS)
Diagnose asthma only with objective evidence of reversible airflow obstruction or bronchial hyperresponsiveness, not on clinical symptoms alone Initiate Step 2 treatment by adding…
25 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock
Insert a catheter-based left ventricular microaxial flow pump in patients with acute cardiogenic shock refractory to medical therapy and inotropic support, as a bridge…
25 Mar 2026
Read summary →
NICE
Cardiology / Cardiovascular
Percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock
Percutaneous insertion of catheter-based left ventricular microaxial flow pumps may be considered for patients with acute cardiogenic shock refractory to medical therapy and intra-aortic…
25 Mar 2026
Read summary →
NICE
Oncology
Kidney cancer: diagnosis and management
I appreciate your request, but I need to let you know that you've provided only the header/metadata of a NICE guideline, not the actual…
19 Mar 2026
Read summary →
NICE
Artificial intelligence (AI) technologies to help detect or characterise colorectal polyps
Use AI-assisted polyp detection systems during colonoscopy to improve adenoma detection rates, particularly in colonoscopists with baseline detection rates below 25% • Implement real-time…
19 Mar 2026
Read summary →
NICE
Mental Health / Psychiatry
Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over
Offer ruxolitinib cream as a treatment option for non-segmental vitiligo in patients aged 12 years and over who have involvement of
17 Mar 2026
Read summary →
NICE
Oncology
Nivolumab with chemotherapy for untreated unresectable or metastatic urothelial cancer (terminated appraisal)
I appreciate your request, but I need to be transparent: the content provided only includes the title, metadata, and editorial notes - it doesn't…
17 Mar 2026
Read summary →
NICE
Oncology
Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment
Use AI technologies as an adjunct to clinical assessment when triaging skin lesions in the urgent suspected cancer pathway, but do not use as…
01 May 2025
Read summary →